儿童喘中的呼吸道微生物组
Gina J van Beveren1, Hager Said2, Marlies A van Houten3
1Spaarne Gasthuis Academy, Hoofddorp and Haarlem, Hoofddorp, The Netherlands; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
The Journal of allergy and clinical immunology
|October 14, 2023
概括
呼吸道微生物组在儿童喘的发展和严重程度方面发挥着关键作用. 显著的微生物特征与喘有关,这表明基于微生物的预防和治疗策略的潜力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 儿科呼吸系统医学 儿科呼吸系统医学
背景情况:
- 喘是一种常见的儿童非传染性疾病,涉及呼吸道炎症和收缩.
- 呼吸道拥有多样化的微生物群,其组成在不同中各不相同.
- 呼吸道微生物组越来越多地与喘病因,疾病过程,严重程度和表型有关.
研究的目的:
- 审查有关呼吸道微生物组在儿童喘中的作用的文献.
- 为了区分微生物组对喘发展和疾病进展的影响.
- 评估微生物群对喘内型和宿主免疫反应的影响.
主要方法:
- 系统性文献综述,重点关注呼吸道微生物群和喘.
- 对区分上呼吸道和下呼吸道微生物的研究进行分析.
- 考虑与年龄相关的变化和喘表型.
主要成果:
- 呼吸道中明显的微生物特征与喘的发展,稳定性和严重程度有关.
- 微生物组与喘的关系在疾病发展和进展之间有所不同.
- 特定的微生物模式与不同的喘内型和免疫反应相关.
结论:
- 呼吸道微生物组与儿童喘的发展和严重程度有很大关系.
- 识别特定的微生物特征为基于微生物组的针对性干预提供了潜力.
- 未来的研究可能会利用这些发现为新的喘预防和治疗策略.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Breathing
59.5K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.5K
Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


